Showing results (181-190 of 220) with videos related to
Sort By:
Pageof 22
Blood|November 1, 1982
Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA)Z A Arlin, M P Fanucchi, T S Gee, et al.Analytical Biochemistry|October 1, 1985
Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolitesJ J Kinahan, L L Samuels, F Farag, et al.Scientific Reports|August 15, 2022
Antibiotic resistance genes of public health importance in livestock and humans in an informal urban community in NepalCristin C W Young, Dibesh Karmacharya, Manisha Bista, et al.Cancer Research|September 1, 1980
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemiaZ A Arlin, R B Sklaroff, T S Gee, et al.Cancer Research|November 1, 1980
Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidineT M Woodcock, T C Chou, C T Tan, et al.Cancer Research|December 1, 1980
Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adultsR P Warrell, T C Chou, C Gordon, et al.Cancer Treatment Reports|January 1, 1977
Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphomaT J Garrett, T S Gee, M D Dowling, et al.Proceedings. Biological Sciences|April 8, 2020
Global shifts in mammalian population trends reveal key predictors of virus spillover riskChristine K Johnson, Peta L Hitchens, Pranav S Pandit, et al.Cancer Treatment Reports|August 1, 1979
Phase I evaluation of tetrahydrouridine combined with cytosine arabinosideP P Wong, V E Currie, R W Mackey, et al.Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.Pageof 22